The Biology of TPI Deficiency and Getting an Accurate Diagnosis

Understanding the biology of triosephosphate isomerase (TPI) deficiency helps explain why it affects so many different parts of the body. While many genetic conditions involve an enzyme that simply “stops working,” TPI deficiency is more complex, often involving a protein that is physically unstable or breaks down too quickly within the cell ^[1].

The Energy Factory Jam

To understand TPI deficiency, it helps to think of glycolysis as a factory assembly line that turns sugar (glucose) into energy (ATP). Halfway through this line, the sugar is split into two different pieces: GAP (glyceraldehyde-3-phosphate) and DHAP (dihydroxyacetone phosphate) ^[2][3].

The assembly line works best when it can utilize both pieces. The TPI enzyme’s job is to reversibly “flip” DHAP into GAP so it can be used efficiently ^[2]. When TPI is deficient:

1. Pathway Efficiency Drops: The cell cannot easily utilize the DHAP pool, which slows down the overall production of energy ^[3].
2. Toxic Buildup: The unused DHAP pieces pile up inside the cells, particularly in red blood cells and nerve tissues, which may cause damage over time ^[4].

Protein Instability: More Than Just Activity

A key discovery in TPI deficiency research is that the amount of stable enzyme often matters as much as how well it works. Some genetic changes (variants) create a TPI enzyme that looks normal in a test tube but is “shaky” or unstable inside a living cell ^[1]. The cell’s internal cleaning system recognizes these shaky proteins as “trash” and destroys them, leaving the cell with a severe shortage of the enzyme ^[1]. This is why a person can have symptoms even if a laboratory test shows some remaining enzyme activity ^[5].

How a Diagnosis is Confirmed

Because TPI deficiency is so rare, doctors use specialized tools to confirm the diagnosis and distinguish it from “look-alike” conditions.

• TPI Enzyme Activity: This test measures how fast the enzyme in red blood cells can convert sugar pieces. A very low level is a strong sign of the disorder ^[4]. Note: If a blood transfusion occurred recently, this test may be inaccurate because it will measure the healthy donor’s enzymes ^[6].
• DHAP Levels: Since DHAP “piles up” when the enzyme is missing, measuring high levels of it in the blood provides additional confirmation ^[4]. However, this is a highly specialized test and may not be routinely available outside of research centers.
• Genetic Testing (TPI1 Gene): Molecular testing looks for changes in the TPI1 gene. To establish the disorder, an individual must inherit a pathogenic or likely pathogenic variant from both parents (autosomal recessive inheritance) ^[2]. A finding of two genetic variants does not automatically confirm a diagnosis if one or both are a Variant of Uncertain Significance (VUS); clinical symptoms and biochemical testing are also required.

Look-Alike Conditions (Differential Diagnosis)

Several other rare enzyme deficiencies can cause similar symptoms, such as hemolytic anemia (the breakdown of red blood cells) and muscle weakness. These are often confused with TPI deficiency before genetic testing is complete:

• GPI Deficiency: Another sugar-processing disorder that causes anemia and, occasionally, neurological issues ^[7].
• Pyruvate Kinase (PK) Deficiency: The most common enzyme-related cause of chronic anemia, though it typically does not cause the progressive nerve issues seen in TPI deficiency ^[8].
• Other Glycolytic Defects: Rare deficiencies like Aldolase A or Phosphofructokinase can also cause muscle breakdown (rhabdomyolysis) and anemia ^[9].

Reading Your Diagnostic Report

A complete diagnostic report is essential for planning care. Ensure your report includes these specific details:

1. HGVS Nomenclature: The exact “code” for the genetic change (e.g., c.315G>C or p.Glu105Asp) ^[2].
2. Zygosity: Whether the person has two identical changes (homozygous) or two different changes (compound heterozygous) ^[2].
3. Variant Classification: Whether the changes are labeled as “Pathogenic,” “Likely Pathogenic,” or “Variant of Uncertain Significance (VUS)” ^[10].
4. Reference Intervals: For enzyme tests, the report should show the result next to the “normal” range for that specific lab ^[11].
5. Phase: If there are two different changes, the report may indicate if they are “in trans” (meaning one came from each parent), which confirms the diagnosis ^[2].